These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 16983622)

  • 1. Symptomatic relapse of HIV-associated cryptococcal meningitis after initial fluconazole monotherapy: the role of fluconazole resistance and immune reconstitution.
    Bicanic T; Harrison T; Niepieklo A; Dyakopu N; Meintjes G
    Clin Infect Dis; 2006 Oct; 43(8):1069-73. PubMed ID: 16983622
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Symptomatic relapse of HIV-associated cryptococcal meningitis in South Africa: the role of inadequate secondary prophylaxis.
    Jarvis JN; Meintjes G; Williams Z; Rebe K; Harrison TS
    S Afr Med J; 2010 Jun; 100(6):378-82. PubMed ID: 20526411
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recurrence of cryptococcal meningitis in HIV-infected patients following immune reconstitution.
    Seddon J; Mangeya N; Miller RF; Corbett EL; Ferrand RA
    Int J STD AIDS; 2009 Apr; 20(4):274-5. PubMed ID: 19304977
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Response to therapy in patients with cryptococcosis and AIDS: Association with in vitro susceptibility to fluconazole.
    Agudelo CA; Muñoz C; Ramírez A; Tobón AM; de Bedout Bact C; Cano LE; Restrepo A
    Rev Iberoam Micol; 2015; 32(4):214-20. PubMed ID: 25637338
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of acute cryptococcal meningitis in HIV infected adults, with an emphasis on resource-limited settings.
    Sloan D; Dlamini S; Paul N; Dedicoat M
    Cochrane Database Syst Rev; 2008 Oct; (4):CD005647. PubMed ID: 18843697
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of cryptococcal meningitis associated with the acquired immunodeficiency syndrome. National Institute of Allergy and Infectious Diseases Mycoses Study Group and AIDS Clinical Trials Group.
    van der Horst CM; Saag MS; Cloud GA; Hamill RJ; Graybill JR; Sobel JD; Johnson PC; Tuazon CU; Kerkering T; Moskovitz BL; Powderly WG; Dismukes WE
    N Engl J Med; 1997 Jul; 337(1):15-21. PubMed ID: 9203426
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A controlled trial of fluconazole or amphotericin B to prevent relapse of cryptococcal meningitis in patients with the acquired immunodeficiency syndrome. The NIAID AIDS Clinical Trials Group and Mycoses Study Group.
    Powderly WG; Saag MS; Cloud GA; Robinson P; Meyer RD; Jacobson JM; Graybill JR; Sugar AM; McAuliffe VJ; Follansbee SE
    N Engl J Med; 1992 Mar; 326(12):793-8. PubMed ID: 1538722
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factors associated with early mycological clearance in HIV-associated cryptococcal meningitis.
    Concha-Velasco F; González-Lagos E; Seas C; Bustamante B
    PLoS One; 2017; 12(3):e0174459. PubMed ID: 28355252
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recurrent Cryptococcal Meningitis in a Late Presenter of HIV: A Rare Case Report and Review of Literature.
    Petrakis V; Angelopoulou CG; Psatha E; Grapsa A; Panopoulou M; Papazoglou D; Panagopoulos P
    Am J Case Rep; 2023 Dec; 24():e941714. PubMed ID: 38083828
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Challenges in diagnosis and management of Cryptococcal immune reconstitution inflammatory syndrome (IRIS) in resource limited settings.
    Musubire AK; Meya BD; Mayanja-Kizza H; Lukande R; Wiesner LD; Bohjanen P; R Boulware RD
    Afr Health Sci; 2012 Jun; 12(2):226-30. PubMed ID: 23056032
    [TBL] [Abstract][Full Text] [Related]  

  • 11. AMBIsome Therapy Induction OptimisatioN (AMBITION): High Dose AmBisome for Cryptococcal Meningitis Induction Therapy in sub-Saharan Africa: Study Protocol for a Phase 3 Randomised Controlled Non-Inferiority Trial.
    Lawrence DS; Youssouf N; Molloy SF; Alanio A; Alufandika M; Boulware DR; Boyer-Chammard T; Chen T; Dromer F; Hlupeni A; Hope W; Hosseinipour MC; Kanyama C; Lortholary O; Loyse A; Meya DB; Mosepele M; Muzoora C; Mwandumba HC; Ndhlovu CE; Niessen L; Schutz C; Stott KE; Wang D; Lalloo DG; Meintjes G; Jaffar S; Harrison TS; Jarvis JN
    Trials; 2018 Nov; 19(1):649. PubMed ID: 30470259
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recent advances in AIDS-related cryptococcal meningitis treatment with an emphasis on resource limited settings.
    Lofgren S; Abassi M; Rhein J; Boulware DR
    Expert Rev Anti Infect Ther; 2017 Apr; 15(4):331-340. PubMed ID: 28111998
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Liposomal amphotericin B (AmBisome) compared with amphotericin B both followed by oral fluconazole in the treatment of AIDS-associated cryptococcal meningitis.
    Leenders AC; Reiss P; Portegies P; Clezy K; Hop WC; Hoy J; Borleffs JC; Allworth T; Kauffmann RH; Jones P; Kroon FP; Verbrugh HA; de Marie S
    AIDS; 1997 Oct; 11(12):1463-71. PubMed ID: 9342068
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Cryptococcal meningoencephalitis related to HIV infection with resistance to fluconazole, relapse, and IRIS].
    Seilmaier M; Hecht A; Guggemos W; Rüdisser K
    Med Klin (Munich); 2009 Jan; 104(1):58-62. PubMed ID: 19142596
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Short-course amphotericin B in addition to sertraline and fluconazole for treatment of HIV-associated cryptococcal meningitis in rural Tanzania.
    Katende A; Mbwanji G; Faini D; Nyuri A; Kalinjuma AV; Mnzava D; Hullsiek KH; Rhein J; Weisser M; Meya DB; Boulware DR; Letang E;
    Mycoses; 2019 Dec; 62(12):1127-1132. PubMed ID: 31461550
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Symptomatic relapse of HIV-associated cryptococcal meningitis: recurrent cryptococcal meningitis or Cryptococcus-related immune reconstitution inflammatory syndrome?
    Jhamb R; Kashyap B; Das S; Berry N; Garg A
    Int J STD AIDS; 2014 Apr; 25(5):369-72. PubMed ID: 24108453
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cryptococcal meningitis and immune reconstitution inflammatory syndrome in a pediatric patient with HIV after switching to second line antiretroviral therapy: a case report.
    Otto SBJ; George PE; Mercedes R; Nabukeera-Barungi N
    BMC Infect Dis; 2020 Jan; 20(1):68. PubMed ID: 31964348
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuroimaging of HIV-associated cryptococcal meningitis: comparison of magnetic resonance imaging findings in patients with and without immune reconstitution.
    Katchanov J; Branding G; Jefferys L; Arastéh K; Stocker H; Siebert E
    Int J STD AIDS; 2016 Feb; 27(2):110-7. PubMed ID: 25693580
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early versus delayed antiretroviral therapy and cerebrospinal fluid fungal clearance in adults with HIV and cryptococcal meningitis.
    Bisson GP; Molefi M; Bellamy S; Thakur R; Steenhoff A; Tamuhla N; Rantleru T; Tsimako I; Gluckman S; Ravimohan S; Weissman D; Tebas P
    Clin Infect Dis; 2013 Apr; 56(8):1165-73. PubMed ID: 23362285
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immune reconstitution inflammatory syndrome in HIV-associated cryptococcal meningitis: a prospective study.
    Bicanic T; Meintjes G; Rebe K; Williams A; Loyse A; Wood R; Hayes M; Jaffar S; Harrison T
    J Acquir Immune Defic Syndr; 2009 Jun; 51(2):130-4. PubMed ID: 19365271
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.